Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEXGet Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of MTEX opened at $7.74 on Monday. The firm has a market capitalization of $14.59 million, a price-to-earnings ratio of -8.70 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.56 and a current ratio of 1.08. Mannatech has a one year low of $7.30 and a one year high of $15.10. The stock’s fifty day moving average is $8.09 and its 200-day moving average is $8.54.

Mannatech (NASDAQ:MTEXGet Free Report) last announced its earnings results on Thursday, March 28th. The company reported ($0.94) earnings per share for the quarter. Mannatech had a negative net margin of 1.31% and a negative return on equity of 15.37%. The firm had revenue of $32.69 million for the quarter.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.